CN102382273B - Preparation method of 17 beta-estradiol molecular-imprinted composite microspheres - Google Patents
Preparation method of 17 beta-estradiol molecular-imprinted composite microspheres Download PDFInfo
- Publication number
- CN102382273B CN102382273B CN201110194705A CN201110194705A CN102382273B CN 102382273 B CN102382273 B CN 102382273B CN 201110194705 A CN201110194705 A CN 201110194705A CN 201110194705 A CN201110194705 A CN 201110194705A CN 102382273 B CN102382273 B CN 102382273B
- Authority
- CN
- China
- Prior art keywords
- microspheres
- estradiol
- monodisperse
- glycidyl methacrylate
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title claims abstract description 203
- 239000004005 microsphere Substances 0.000 title claims abstract description 138
- 229960005309 estradiol Drugs 0.000 title claims abstract description 104
- 239000002131 composite material Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 238000000605 extraction Methods 0.000 claims abstract description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims abstract description 4
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 claims description 76
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 44
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 42
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 37
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 28
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 27
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 27
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 23
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims description 22
- 239000004793 Polystyrene Substances 0.000 claims description 21
- 229920002223 polystyrene Polymers 0.000 claims description 21
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 19
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 19
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 17
- 229920002554 vinyl polymer Polymers 0.000 claims description 16
- 229910015900 BF3 Inorganic materials 0.000 claims description 14
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 239000001301 oxygen Substances 0.000 claims description 13
- 229910052760 oxygen Inorganic materials 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 239000006185 dispersion Substances 0.000 claims description 12
- 238000006116 polymerization reaction Methods 0.000 claims description 12
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 11
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 11
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 10
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 10
- 229910001873 dinitrogen Inorganic materials 0.000 claims description 10
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 10
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 8
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 8
- 239000002270 dispersing agent Substances 0.000 claims description 8
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims description 6
- 229930182833 estradiol Natural products 0.000 claims description 5
- 238000001132 ultrasonic dispersion Methods 0.000 claims description 5
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- 238000006136 alcoholysis reaction Methods 0.000 claims description 3
- 238000006392 deoxygenation reaction Methods 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000006213 oxygenation reaction Methods 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 2
- -1 glycidyl methacrylate Ester Chemical class 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 150000002009 diols Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 16
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 229940011871 estrogen Drugs 0.000 abstract description 4
- 239000000262 estrogen Substances 0.000 abstract description 4
- 238000001179 sorption measurement Methods 0.000 abstract description 4
- 238000004811 liquid chromatography Methods 0.000 abstract description 2
- 238000002414 normal-phase solid-phase extraction Methods 0.000 abstract description 2
- 239000003463 adsorbent Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000002203 pretreatment Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 230000014759 maintenance of location Effects 0.000 description 11
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 7
- 229960001348 estriol Drugs 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 229960003399 estrone Drugs 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 5
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 5
- 229960002504 capsaicin Drugs 0.000 description 5
- 235000017663 capsaicin Nutrition 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229940016667 resveratrol Drugs 0.000 description 5
- 235000021283 resveratrol Nutrition 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 238000013375 chromatographic separation Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 239000003687 estradiol congener Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- YWAJAJKSWBALGM-UHFFFAOYSA-N CCCCCC.[O] Chemical compound CCCCCC.[O] YWAJAJKSWBALGM-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 2
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 125000005395 methacrylic acid group Chemical group 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 150000000307 17β-estradiols Chemical class 0.000 description 1
- BYMMIQCVDHHYGG-UHFFFAOYSA-N Cl.OP(O)(O)=O Chemical compound Cl.OP(O)(O)=O BYMMIQCVDHHYGG-UHFFFAOYSA-N 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ONYAGMNYDLMVKG-UHFFFAOYSA-N O1CCOCC1.C(C(=C)C)(=O)OCC1CO1 Chemical compound O1CCOCC1.C(C(=C)C)(=O)OCC1CO1 ONYAGMNYDLMVKG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- UJKWLAZYSLJTKA-UHFFFAOYSA-N edma Chemical compound O1CCOC2=CC(CC(C)NC)=CC=C21 UJKWLAZYSLJTKA-UHFFFAOYSA-N 0.000 description 1
- 238000010556 emulsion polymerization method Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012673 precipitation polymerization Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010558 suspension polymerization method Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
技术领域 technical field
本发明属于材料技术领域,具体涉及一种分析测定生物样品和食品样品中的17β-雌二醇的分子印迹复合微球。The invention belongs to the technical field of materials, and in particular relates to a molecularly imprinted composite microsphere for analyzing and measuring 17β-estradiol in biological samples and food samples.
背景技术 Background technique
17β-雌二醇(17β-Estradiol)是人工合成雌激素的一种,它主要用于医学上治疗妇女更年期综合症等疾病,但长期摄入17β-雌二醇会产生一些副作用,并增加某些疾病的发病危险,鉴于具有这些风险,故而国家严禁在食品中使用17β-雌二醇等人工合成雌激素。但不乏一些不法分子为强化其产品功能,降低成本而添加17β-雌二醇等具有的雌激素样作用的人工合成雌激素。此外,滥用同化激素,对人和动物健康,对社会和生态环境都会造成直接或潜在的危害。因此对食品、保健食品中17β-雌二醇等人工合成的雌激素监测也是保证此类食品卫生安全的必要措施。17β-Estradiol (17β-Estradiol) is a kind of synthetic estrogen, it is mainly used in medicine to treat women's climacteric syndrome and other diseases, but long-term intake of 17β-Estradiol will produce some side effects and increase certain In view of these risks, the country strictly prohibits the use of synthetic estrogens such as 17β-estradiol in food. However, there are some criminals who add 17β-estradiol and other synthetic estrogens with estrogen-like effects in order to strengthen their product functions and reduce costs. In addition, the abuse of anabolic hormones will cause direct or potential harm to human and animal health, society and the ecological environment. Therefore, the monitoring of synthetic estrogens such as 17β-estradiol in food and health food is also a necessary measure to ensure the hygiene and safety of such food.
17β-雌二醇可通过生命体的代谢进入环境,或作为雌性激素类药物生产的母体化合物随工业废水进入环境,以致在水生物中残留,由食物链进入人体,而其代谢产物又与人类癌症有密切的关系。因此,它引起的食品营养和安全问题不容忽视,对这类物质的存在水平和生物学活性的研究具有重要的现实意义。由于食品中的残留待测药物浓度低且波动范围大、样品基质复杂、干扰物质多、样品基质和待测组分的不确定性等特点,检测前需去除样品中干扰杂质,富集痕迹量待测目的组分。17β-estradiol can enter the environment through the metabolism of living organisms, or enter the environment as the parent compound produced by estrogen drugs along with industrial wastewater, so that it remains in aquatic organisms and enters the human body through the food chain, and its metabolites are related to human cancer. have a close relationship. Therefore, the food nutrition and safety problems caused by it cannot be ignored, and the research on the existence level and biological activity of this kind of substances has important practical significance. Due to the low concentration and large fluctuation range of the residual drug to be tested in food, the complex sample matrix, many interfering substances, and the uncertainty of the sample matrix and the components to be tested, it is necessary to remove the interfering impurities in the sample and enrich the trace amount before testing. The target component to be tested.
分子印迹聚合物(MIPs)具有特异性识别,可用于复杂基质的样品前处理,且制备简单、性质稳定和可重复使用,已在分离科学、生物医学、传感器技术和化学反应的控制等方面都得到了广泛的应用。但现有的制备MPIMs方法都存在明显的局限性:本体聚合得到的聚合物为块状,使用前须经过研磨、筛分等处理,尺寸和形状不规则使得样品处理困难,工作繁琐、费时,且产率低(一般<50%),应用效率大幅降低;沉淀聚合法对溶剂的要求高,难以得到广泛应用;乳液聚合法制得的MPIMs粒径小(<1μm),不适合在液相色谱中使用且吸附后不易分离;利用球形硅胶表面印迹或牺牲硅胶法时,硅胶表面的羟基会影响功能单体与模板分子间的作用力,以致MPIMs识别能力较弱;悬浮聚合法虽制备工艺简单,但获得的MPIMs粒径分布宽,需经繁琐的分级处理才可使用;多步溶胀聚合法虽能制得微米级且粒径较均匀的MPIMs,经简单的洗涤即可使用,但需经多步溶胀,过程较为繁琐、制备周期较长,难以实现工业化。相比之下,分子印迹聚合物微球性能较好、制备与使用较方便,特别适用于分析检测、传感器阵列和分离组件。因此,分子印迹聚合物微球的制备和应用研究成为分子印迹技术的研究热点之一。表面印迹的结合位点位于聚合物的表面,模板分子易于洗脱,可提高结合容量;再结合时目标分子无需进入其刚性结构,大大加快了结合的动力学过程。但这种方法目前使用的基质主要局限于硅胶,使用微粒硅胶要特别注意它的使用pH范围是2~7.5,若过碱(pH>7.5),硅胶会粉碎或溶解;若过酸(pH<2),键合相的化学键会断裂。反应结束后去除基质比较麻烦,一般采用氢氟酸腐蚀的方法,但对聚合物的骨架结构有一定的不良影响。Molecularly imprinted polymers (MIPs) have specific recognition, can be used for sample pretreatment of complex matrices, and are easy to prepare, stable and reusable, and have been used in separation science, biomedicine, sensor technology and control of chemical reactions. Has been widely used. However, the existing methods for preparing MPIMs have obvious limitations: the polymer obtained by bulk polymerization is in the form of a block, which must be ground and sieved before use. The irregular size and shape make sample processing difficult, cumbersome and time-consuming. And the yield is low (generally <50%), and the application efficiency is greatly reduced; the precipitation polymerization method has high requirements for solvents, and is difficult to be widely used; the MPIMs obtained by the emulsion polymerization method have a small particle size (<1 μm), which is not suitable for liquid chromatography. It is not easy to separate after adsorption; when using spherical silica gel surface imprinting or sacrificial silica gel method, the hydroxyl groups on the silica gel surface will affect the force between functional monomers and template molecules, so that the recognition ability of MPIMs is weak; although the suspension polymerization method has a simple preparation process , but the obtained MPIMs have a wide particle size distribution and can only be used after tedious classification treatment; although the multi-step swelling polymerization method can produce micron-sized and uniform particle size MPIMs, it can be used after simple washing, but it needs to be processed Multi-step swelling, the process is more cumbersome, the preparation cycle is longer, and it is difficult to realize industrialization. In contrast, molecularly imprinted polymer microspheres have better performance, are more convenient to prepare and use, and are especially suitable for analytical detection, sensor arrays and separation components. Therefore, the preparation and application of molecularly imprinted polymer microspheres has become one of the research hotspots of molecularly imprinted technology. The binding site of the surface imprint is located on the surface of the polymer, and the template molecule is easy to elute, which can increase the binding capacity; the target molecule does not need to enter its rigid structure when recombining, which greatly speeds up the kinetic process of binding. However, the matrix currently used in this method is mainly limited to silica gel. When using particulate silica gel, special attention should be paid to its pH range of 2 to 7.5. If it is too alkaline (pH>7.5), the silica gel will be crushed or dissolved; if it is too acidic (pH< 2), the chemical bonds of the bonded phase will be broken. After the reaction, it is troublesome to remove the matrix. Generally, hydrofluoric acid corrosion is used, but it has a certain adverse effect on the skeleton structure of the polymer.
发明内溶Invention of internal dissolution
本发明所要解决的技术问题在于克服上述制备方法的缺点,提供一种反应条件温和,产物稳定性好、识别能力强的17β-雌二醇分子印迹复合微球的制备方法。The technical problem to be solved by the present invention is to overcome the disadvantages of the above-mentioned preparation methods, and provide a preparation method of 17β-estradiol molecularly imprinted composite microspheres with mild reaction conditions, good product stability and strong recognition ability.
解决上述技术问题所采用的技术方案由下述步骤组成:The technical solution adopted to solve the above technical problems consists of the following steps:
1、合成单分散聚苯乙烯分散液1. Synthesis of monodisperse polystyrene dispersion
将苯乙烯、偶氮二异丁腈、聚乙烯吡咯烷酮加入无水乙醇中,苯乙烯与偶氮二异丁腈、聚乙烯吡咯烷酮、无水乙醇的质量比为1∶0.01~0.04∶0.1~0.3∶7.5~9,超声分散,通氮气除氧,搅拌,70℃聚合反应24小时,制备成聚苯乙烯;将聚苯乙烯用质量分数为0.2%的十二烷基硫酸钠水溶液超声分散,得到单分散聚苯乙烯分散液。Add styrene, azobisisobutyronitrile, and polyvinylpyrrolidone into absolute ethanol, and the mass ratio of styrene to azobisisobutyronitrile, polyvinylpyrrolidone, and absolute ethanol is 1:0.01~0.04:0.1~0.3 : 7.5 ~ 9, ultrasonic dispersion, nitrogen deoxygenation, stirring, 70 ° C polymerization reaction for 24 hours, prepared into polystyrene; the polystyrene is ultrasonically dispersed with a mass fraction of 0.2% sodium lauryl sulfate aqueous solution to obtain Monodisperse polystyrene dispersion.
上述聚乙烯吡咯烷酮的分子量为10000~70000,由中国·派尼化学试剂厂·郑州提供。The above-mentioned polyvinylpyrrolidone has a molecular weight of 10,000-70,000 and is provided by Paini Chemical Reagent Factory, Zhengzhou, China.
2、制备单分散交联甲基丙烯酸环氧丙酯微球2. Preparation of monodisperse cross-linked glycidyl methacrylate microspheres
将过氧化苯甲酰、甲基丙烯酸环氧丙酯、乙二醇二甲基丙烯酸酯、分散剂水溶液加入环己醇与甲苯的混合溶剂中,甲苯与环己醇、过氧化苯甲酰、甲基丙烯酸环氧丙酯、乙二醇二甲基丙烯酸酯、分散剂水溶液的质量比为1∶2∶0.15∶2∶3∶60,用细胞破碎仪在功率为300~500W下超声,每间隔10~20秒超声1次,每次超声10~20秒,超声乳化至上层无油滴,加入到步骤1得到的单分散聚苯乙烯分散液中,甲基丙烯酸环氧丙酯与单分散聚苯乙烯分散液中聚苯乙烯的质量比为1∶0.1,30℃搅拌溶胀10小时,通氮气除氧,70℃聚合反应24小时,过滤,依次用甲醇、丙酮洗涤,60℃真空干燥4小时,制备成单分散交联甲基丙烯酸环氧丙酯微球。Benzoyl peroxide, glycidyl methacrylate, ethylene glycol dimethacrylate, dispersant aqueous solution are added in the mixed solvent of cyclohexanol and toluene, toluene and cyclohexanol, benzoyl peroxide, The mass ratio of glycidyl methacrylate, ethylene glycol dimethacrylate, and dispersant aqueous solution is 1:2:0.15:2:3:60, and the cell disruptor is used to ultrasonicate at a power of 300-500W. Ultrasonic 1 time at intervals of 10-20 seconds, 10-20 seconds each time, ultrasonically emulsify until the upper layer has no oil droplets, add to the monodisperse polystyrene dispersion obtained in step 1, glycidyl methacrylate and monodisperse The mass ratio of polystyrene in the polystyrene dispersion is 1:0.1, stirred and swelled at 30°C for 10 hours, purged with nitrogen to remove oxygen, polymerized at 70°C for 24 hours, filtered, washed with methanol and acetone in sequence, and vacuum-dried at 60°C for 4 Hours, monodisperse cross-linked glycidyl methacrylate microspheres were prepared.
上述分散剂水溶液中的分散剂为十二烷基硫酸钠和聚乙烯醇,十二烷基硫酸钠的质量分数为0.2%,聚乙烯醇的质量分数为2%,所述的聚乙烯醇的聚合度为1700,醇解度为88%,由天津天大化工实验厂提供。The dispersant in the above-mentioned dispersant aqueous solution is sodium lauryl sulfate and polyvinyl alcohol, and the mass fraction of sodium lauryl sulfate is 0.2%, and the mass fraction of polyvinyl alcohol is 2%, and the mass fraction of described polyvinyl alcohol The degree of polymerization is 1700, and the degree of alcoholysis is 88%, provided by Tianjin Tianda Chemical Experimental Factory.
3、抽提单分散交联甲基丙烯酸环氧丙酯微球3. Extraction of monodisperse cross-linked glycidyl methacrylate microspheres
将步骤2制备的单分散交联甲基丙烯酸环氧丙酯微球用甲苯在索式提取器中140℃抽提48小时,依次用无水乙醇、丙酮洗涤,干燥,得到单分散多孔交联甲基丙烯酸环氧丙酯微球。Extract the monodisperse crosslinked glycidyl methacrylate microspheres prepared in
4、单分散交联甲基丙烯酸环氧丙酯微球表面键合乙烯基4. Monodisperse cross-linked glycidyl methacrylate microspheres surface-bonded vinyl
将步骤3制备的单分散多孔交联甲基丙烯酸环氧丙酯微球加入1,4-二氧六环中,每100mL 1,4-二氧六环中加入3~10g单分散多孔交联甲基丙烯酸环氧丙酯微球,室温搅拌溶胀4~12小时,通氮气除氧,加入甲基丙烯酸羟乙酯与1,4-二氧六环、三氟化硼乙醚的质量比为1∶2~5∶4~6的混合液,单分散多孔交联甲基丙烯酸环氧丙酯微球与甲基丙烯酸羟乙酯的质量比为1∶0.1~2,30~60℃搅拌8~15小时,过滤,产物依次用1,4-二氧六环、甲醇、蒸馏水、丙酮洗涤,真空干燥,得到表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球。Add the monodisperse porous cross-linked glycidyl methacrylate microspheres prepared in
5、合成17β-雌二醇分子印迹复合微球5. Synthesis of 17β-estradiol molecularly imprinted composite microspheres
以乙腈为溶剂,超声分散17β-雌二醇、甲基丙烯酸、表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球,室温搅拌溶胀4~12小时,加入乙二醇二甲基丙烯酸酯、偶氮二异丁腈,17β-雌二醇与表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球丙酯微球的质量比为1∶20~120,17β-雌二醇与甲基丙烯酸、乙二醇二甲基丙烯酸酯、偶氮二异丁腈的摩尔比为1∶2~12∶8~20∶1~2,通氮气除氧,60~70℃聚合反应16~48小时,产物用甲醇与乙酸的体积比为8∶2的洗脱液洗脱,除去17β-雌二醇,先用蒸馏水洗至中性,再用甲醇洗涤,真空干燥,制备成17β-雌二醇分子印迹复合微球。Using acetonitrile as a solvent, ultrasonically disperse 17β-estradiol, methacrylic acid, and surface-bonded vinyl monodisperse crosslinked glycidyl methacrylate microspheres, stir and swell at room temperature for 4 to 12 hours, add ethylene glycol di The mass ratio of methacrylate, azobisisobutyronitrile, 17β-estradiol and surface-bonded vinyl monodisperse cross-linked glycidyl methacrylate microspheres to propyl ester microspheres is 1:20-120 , the molar ratio of 17β-estradiol to methacrylic acid, ethylene glycol dimethacrylate, and azobisisobutyronitrile is 1:2~12:8~20:1~2, nitrogen deoxygenation, 60 Polymerization at ~70°C for 16 to 48 hours, the product was eluted with an eluent with a volume ratio of methanol to acetic acid of 8:2 to remove 17β-estradiol, washed with distilled water until neutral, then washed with methanol, vacuum dried to prepare 17β-estradiol molecularly imprinted composite microspheres.
本发明的单分散交联甲基丙烯酸环氧丙酯微球表面键合乙烯基步骤4中,单分散多孔交联甲基丙烯酸环氧丙酯微球与甲基丙烯酸羟乙酯的最佳质量比为1∶1,甲基丙烯酸羟乙酯与1,4-二氧六环、三氟化硼乙醚的最佳质量比为1∶2.6∶5。The best quality of monodisperse porous crosslinked glycidyl methacrylate microspheres and hydroxyethyl methacrylate in
本发明的单分散交联甲基丙烯酸环氧丙酯微球表面键合乙烯基步骤4中,最佳将步骤3制备的单分散多孔交联甲基丙烯酸环氧丙酯微球加入1,4-二氧六环中,室温搅拌溶胀6小时,通氮气除氧,加入1,4-二氧六环与甲基丙烯酸羟乙酯、三氟化硼乙醚的混合液,45℃搅拌12小时,得到表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球。In
本发明的合成17β-雌二醇分子印迹复合微球步骤5中,17β-雌二醇与表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球的最佳质量比为1∶40,17β-雌二醇与甲基丙烯酸、乙二醇二甲基丙烯酸酯、偶氮二异丁腈的最佳摩尔比为1∶4∶10∶1.2。In step 5 of synthesizing 17β-estradiol molecularly imprinted composite microspheres of the present invention, the optimal mass ratio of 17β-estradiol to monodisperse cross-linked glycidyl methacrylate microspheres bound to vinyl on the surface is 1 : 40, the optimal molar ratio of 17β-estradiol to methacrylic acid, ethylene glycol dimethacrylate and azobisisobutyronitrile is 1: 4: 10: 1.2.
本发明的合成17β-雌二醇分子印迹复合微球步骤5中,最佳将17β-雌二醇、甲基丙烯酸溶于乙腈中,加入步骤4得到的表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球,超声分散,室温搅拌溶胀6小时,加入乙二醇二甲基丙烯酸酯、偶氮二异丁腈,通氮气除氧,70℃聚合反应24小时。In step 5 of the synthesis of 17β-estradiol molecularly imprinted composite microspheres of the present invention, it is best to dissolve 17β-estradiol and methacrylic acid in acetonitrile, and add the monodisperse cross-linking of surface-bonded vinyl groups obtained in
本发明以1,4-二氧六环为溶剂,制备表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球,以表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球为载体,采用表面印迹技术制备成17β-雌二醇分子印迹复合微球,该方法反应条件温和,所得产物稳定性好,对17β-雌二醇的识别能力强、吸附速度快,可用于建立简便的提取、控化和浓缩样品预处理,对含雌激素产品的质量和成分进行评估,同时可用于经受高流速高压力操作的高效液相色谱,大大提高柱效与重现性。另外,由于印迹的结合位点位于聚合物的表面,模板分子易于洗脱,结合时目标分子无需进入其刚性结构,大大加快了吸附与解吸的动力学过程,可将其用作快速、高效的固相萃取吸附剂。The invention uses 1,4-dioxane as a solvent to prepare monodisperse crosslinked glycidyl methacrylate microspheres with vinyl groups bonded on the surface, and monodisperse crosslinked methacrylic acid rings with vinyl groups bonded to the surface Oxypropyl ester microspheres are used as the carrier, and 17β-estradiol molecularly imprinted composite microspheres are prepared by surface imprinting technology. This method has mild reaction conditions, and the product has good stability. Fast, can be used to establish simple extraction, chemical control and concentrated sample pretreatment, to evaluate the quality and composition of estrogen-containing products, and can be used in high-performance liquid chromatography with high flow rate and high pressure operation, greatly improving column efficiency and gravity Presentity. In addition, since the imprinted binding site is located on the surface of the polymer, the template molecule is easy to elute, and the target molecule does not need to enter its rigid structure during binding, which greatly speeds up the kinetic process of adsorption and desorption, and can be used as a fast and efficient Solid Phase Extraction Sorbent.
附图说明 Description of drawings
图1是17β-雌二醇、白藜芦醇和辣椒碱在印迹柱上的色谱分离图。Figure 1 is a chromatographic separation diagram of 17β-estradiol, resveratrol and capsaicin on an imprinted column.
图2是17β-雌二醇、白藜芦醇和辣椒碱在非印迹柱上的色谱分离图。Fig. 2 is a chromatographic separation diagram of 17β-estradiol, resveratrol and capsaicin on a non-imprinted column.
图3是17β-雌二醇和雌酮在印迹柱上的色谱分离图。Fig. 3 is a chromatographic separation diagram of 17β-estradiol and estrone on an imprinted column.
图4是17β-雌二醇和雌酮在非印迹柱上的色谱分离图。Fig. 4 is a chromatographic separation diagram of 17β-estradiol and estrone on a non-imprinted column.
具体实施方式Detailed ways
下面结合附图和实施例对本发明进一步详细说明,但本发明不限于这些实施例。The present invention will be described in further detail below in conjunction with the accompanying drawings and embodiments, but the present invention is not limited to these embodiments.
实施例1Example 1
1、合成单分散聚苯乙烯分散液1. Synthesis of monodisperse polystyrene dispersion
将苯乙烯10.908g、偶氮二异丁腈0.2406g、分子量为10000~70000的聚乙烯吡咯烷酮1.5006g加入盛有96g无水乙醇的250mL单口烧瓶中,苯乙烯与偶氮二异丁腈、聚乙烯吡咯烷酮、无水乙醇的质量比为1∶0.02∶014∶8.8,用超声波清洗器在功率为80W下超声分散20分钟,通氮气15分钟除氧,搅拌,70℃聚合反应24小时,反应结束后,离心除去溶剂,用无水乙醇洗涤,制备成聚苯乙烯;将0.2g聚苯乙烯用超声波清洗器在功率为80W下超声分散于10mL质量分数为0.2%的十二烷基硫酸钠水溶液中,得到单分散聚苯乙烯分散液。Add 10.908g of styrene, 0.2406g of azobisisobutyronitrile, and 1.5006g of polyvinylpyrrolidone with a molecular weight of 10,000 to 70,000 into a 250mL single-necked flask filled with 96g of absolute ethanol. The mass ratio of vinylpyrrolidone and absolute ethanol is 1:0.02:014:8.8, use an ultrasonic cleaner to disperse ultrasonically for 20 minutes at a power of 80W, blow nitrogen for 15 minutes to remove oxygen, stir, and polymerize at 70°C for 24 hours, and the reaction is over Finally, centrifuge to remove the solvent, wash with absolute ethanol, and prepare polystyrene; 0.2g polystyrene is ultrasonically dispersed in 10mL of 0.2% sodium lauryl sulfate aqueous solution with an ultrasonic cleaner at a power of 80W , a monodisperse polystyrene dispersion was obtained.
2、制备单分散交联甲基丙烯酸环氧丙酯微球2. Preparation of monodisperse cross-linked glycidyl methacrylate microspheres
将过氧化苯甲酰0.1667g、甲基丙烯酸环氧丙酯2.064g、乙二醇二甲基丙烯酸酯3.03g、十二烷基硫酸钠与聚乙烯醇(醇解度为88%)的混合物水溶液62.35g加入盛有1.92g环己醇与1.0392g甲苯的250mL烧杯中,甲苯与环己醇、过氧化苯甲酰、甲基丙烯酸环氧丙酯、乙二醇二甲基丙烯酸酯、十二烷基硫酸钠与聚乙烯醇的混合物水溶液的质量比为1∶2∶0.15∶2∶3∶60,用细胞破碎仪在功率为400W下超声,每间隔15秒超声1次,每次超声15秒,超声乳化至上层无油滴,加入到步骤1得到的单分散聚苯乙烯分散液中,甲基丙烯酸环氧丙酯与单分散聚苯乙烯分散液中聚苯乙烯的质量比为1∶0.1,120转/分钟搅拌,30℃溶胀10小时,通氮气20分钟除氧,70℃聚合反应24小时,用玻砂漏斗抽滤,用70℃蒸馏水洗涤,再依次用甲醇、丙酮洗涤,60℃真空干燥4小时,制备成单分散交联甲基丙烯酸环氧丙酯微球。A mixture of benzoyl peroxide 0.1667g, glycidyl methacrylate 2.064g, ethylene glycol dimethacrylate 3.03g, sodium lauryl sulfate and polyvinyl alcohol (88% degree of alcoholysis) Add 62.35g of aqueous solution into a 250mL beaker containing 1.92g cyclohexanol and 1.0392g toluene, toluene and cyclohexanol, benzoyl peroxide, glycidyl methacrylate, ethylene glycol dimethacrylate, ten The mass ratio of the mixture aqueous solution of dialkyl sodium sulfate and polyvinyl alcohol is 1:2:0.15:2:3:60, sonicate with a cell disruptor at a power of 400W, and sonicate once every 15 seconds. 15 seconds, ultrasonic emulsification to the upper layer without oil droplets, join in the monodisperse polystyrene dispersion obtained in step 1, the mass ratio of glycidyl methacrylate and polystyrene in the monodisperse polystyrene dispersion is 1 : 0.1, stirred at 120 rpm, swelled at 30°C for 10 hours, purged with nitrogen for 20 minutes to remove oxygen, polymerized at 70°C for 24 hours, filtered with glass sand funnel, washed with distilled water at 70°C, and then washed with methanol and acetone in sequence. Vacuum drying at 60°C for 4 hours to prepare monodisperse crosslinked glycidyl methacrylate microspheres.
上述的十二烷基硫酸钠与聚乙烯醇的混合物水溶液中,十二烷基硫酸钠的质量分数为0.2%,聚乙烯醇的质量分数为2%,聚乙烯醇的聚合度为1700,醇解度为88%。In the above-mentioned mixture aqueous solution of sodium lauryl sulfate and polyvinyl alcohol, the mass fraction of sodium lauryl sulfate is 0.2%, the mass fraction of polyvinyl alcohol is 2%, the polymerization degree of polyvinyl alcohol is 1700, alcohol The resolution is 88%.
3、抽提单分散交联甲基丙烯酸环氧丙酯微球3. Extraction of monodisperse cross-linked glycidyl methacrylate microspheres
将步骤2制备的单分散交联甲基丙烯酸环氧丙酯微球置于索式提取器中,加入50mL甲苯,140℃抽提48小时,依次用无水乙醇、丙酮洗涤,在真空度为0.06MPa下60℃干燥3小时,得到单分散多孔交联甲基丙烯酸环氧丙酯微球。Put the monodisperse cross-linked glycidyl methacrylate microspheres prepared in
4、单分散交联甲基丙烯酸环氧丙酯微球表面键合乙烯基4. Monodisperse cross-linked glycidyl methacrylate microspheres surface-bonded vinyl
将步骤3制备的单分散多孔交联甲基丙烯酸环氧丙酯微球2.0g加入50mL 1,4-二氧六环中,200转/分钟搅拌,室温溶胀6小时,通氮气20分钟除氧,加入2.0g甲基丙烯酸羟乙酯、5.2g 1,4-二氧六环、10.0g三氟化硼乙醚的混合液,甲基丙烯酸羟乙酯与1,4-二氧六环、三氟化硼乙醚的质量比为1∶2.6∶5,单分散多孔交联甲基丙烯酸环氧丙酯微球与甲基丙烯酸羟乙酯的质量比为1∶1,45℃搅拌12小时,过滤,产物依次用1,4-二氧六环、甲醇、蒸馏水、丙酮洗涤,30℃真空干燥2小时,得到表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球。Add 2.0 g of the monodisperse porous cross-linked glycidyl methacrylate microspheres prepared in
5、合成17β-雌二醇分子印迹复合微球5. Synthesis of 17β-estradiol molecularly imprinted composite microspheres
将17β-雌二醇20mg(0.078mmol)、甲基丙烯酸27μL(0.32mmol)溶于15mL乙腈中,加入步骤4得到的表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球0.8g,用超声波清洗器在功率为80W下超声分散5分钟,200转/分钟搅拌,室温溶胀6小时,加入乙二醇二甲基丙烯酸酯147μL(0.774mmol)、偶氮二异丁腈15mg(0.094mmol),17β-雌二醇与表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球的质量比为1∶40,17β-雌二醇与甲基丙烯酸、乙二醇二甲基丙烯酸酯、偶氮二异丁腈的摩尔比为1∶4∶10∶1.2,通氮气20分钟除氧,70℃聚合反应24小时,产物先依次用蒸馏水、甲醇洗涤,再用甲醇与乙酸的体积比为8∶2的洗脱液洗脱24小时,除去17β-雌二醇,然后用蒸馏水洗至中性,再用甲醇洗涤,30℃真空干燥2小时,制备成17β-雌二醇分子印迹复合微球。Dissolve 20 mg (0.078 mmol) of 17β-estradiol and 27 μL (0.32 mmol) of methacrylic acid in 15 mL of acetonitrile, and add the monodisperse cross-linked glycidyl methacrylate microspheres bound to vinyl groups on the surface obtained in
对比实施例1Comparative Example 1
按照实施例1步骤1~4的方法,制备成表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球。不添加模板分子17β-雌二醇,直接将甲基丙烯酸27μL(0.32mmol)溶于15mL乙腈中,加入0.8g表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球,用超声波清洗器在功率为80W下超声分散5分钟,200转/分钟搅拌,室温溶胀6小时,加入乙二醇二甲基丙烯酸酯147μL(0.774mmol)、偶氮二异丁腈15mg(0.094mmol),通氮气20分钟除氧,70℃聚合反应24小时,产物依次用蒸馏水、甲醇洗涤,30℃真空干燥2小时,制备成非分子印迹复合微球。According to the method of Steps 1-4 of Example 1, monodisperse cross-linked glycidyl methacrylate microspheres with vinyl groups bonded on the surface were prepared. Without adding the template molecule 17β-estradiol, directly dissolve 27 μL (0.32 mmol) of methacrylic acid in 15 mL of acetonitrile, add 0.8 g of monodisperse cross-linked glycidyl methacrylate microspheres with vinyl groups on the surface, and use Ultrasonic dispersion with an ultrasonic cleaner at a power of 80W for 5 minutes, stirring at 200 rpm, swelling at room temperature for 6 hours, adding 147 μL (0.774 mmol) of ethylene glycol dimethacrylate and 15 mg (0.094 mmol) of azobisisobutyronitrile , deoxygenated by nitrogen gas for 20 minutes, polymerized at 70°C for 24 hours, washed with distilled water and methanol in turn, and vacuum-dried at 30°C for 2 hours to prepare non-molecularly imprinted composite microspheres.
实施例2Example 2
在实施例1的单分散交联甲基丙烯酸环氧丙酯微球表面键合乙烯基步骤4中,将步骤3制备的单分散多孔交联甲基丙烯酸环氧丙酯微球1.6g加入53.2mL 1,4-二氧六环中,200转/分钟搅拌,室温溶胀6小时,通氮气20分钟除氧,加入0.16g甲基丙烯酸羟乙酯、0.32g 1,4-二氧六环、0.64g三氟化硼乙醚的混合液,甲基丙烯酸羟乙酯与1,4-二氧六环、三氟化硼乙醚的质量比为1∶2∶4,单分散多孔交联甲基丙烯酸环氧丙酯微球与甲基丙烯酸羟乙酯的质量比为1∶0.1,该步骤的其他步骤与实施例1相同。在合成17β-雌二醇分子印迹复合微球步骤5中,将17β-雌二醇40mg(0.156mmol)、甲基丙烯酸26μL(0.312mmol)溶于15mL乙腈中,加入步骤4得到的表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球0.8g,用超声波清洗器在功率为80W下超声分散5分钟,200转/分钟,室温溶胀6小时,加入乙二醇二甲基丙烯酸酯237μL(1.248mmol)、偶氮二异丁腈26mg(0.156mmol),17β-雌二醇与表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球的质量比为1∶20,17β-雌二醇与甲基丙烯酸、乙二醇二甲基丙烯酸酯、偶氮二异丁腈的摩尔比为1∶2∶8∶1,该步骤的其他步骤与实施例1相同。其他步骤与实施例1相同,制备成17β-雌二醇分子印迹复合微球。In
实施例3Example 3
在实施例1的单分散交联甲基丙烯酸环氧丙酯微球表面键合乙烯基步骤4中,将步骤3制备的单分散多孔交联甲基丙烯酸环氧丙酯微球1.6g加入16mL 1,4-二氧六环中,200转/分钟搅拌,室温溶胀6小时,通氮气20分钟除氧,加入3.2g甲基丙烯酸羟乙酯、16g 1,4-二氧六环、19.2g三氟化硼乙醚的混合液,甲基丙烯酸羟乙酯与1,4-二氧六环、三氟化硼乙醚的质量比为1∶5∶6,单分散多孔交联甲基丙烯酸环氧丙酯微球与甲基丙烯酸羟乙酯的质量比为1∶2,该步骤的其他步骤与实施例1相同。在合成17β-雌二醇分子印迹复合微球步骤5中,将17β-雌二醇6.7mg(0.026mmol)、甲基丙烯酸25μL(0.31mmol)溶于15mL乙腈中,加入步骤4得到的表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球0.8g,用超声波清洗器在功率为80W下超声分散5分钟,200转/分钟,室温溶胀6小时,加入乙二醇二甲基丙烯酸酯100μL(0.52mmol)、偶氮二异丁腈9.3mg(0.056mmol),17β-雌二醇与表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球的质量比为1∶120,17β-雌二醇与甲基丙烯酸、乙二醇二甲基丙烯酸酯、偶氮二异丁腈的摩尔比为1∶12∶20∶2,该步骤的其他步骤与实施例1相同。其他步骤与实施例1相同,制备成17β-雌二醇分子印迹复合微球。In
实施例4Example 4
在实施例1~3的单分散交联甲基丙烯酸环氧丙酯微球表面键合乙烯基步骤4中,将单分散多孔交联甲基丙烯酸环氧丙酯微球加入1,4-二氧六环中,200转/分钟搅拌,室温溶胀4小时,通氮气20分钟除氧,加入甲基丙烯酸羟乙酯与1,4-二氧六环、三氟化硼乙醚的混合液,30℃搅拌15小时,该步骤的其他步骤与相应实施例相同。其他步骤与相应实施例相同,制备成17β-雌二醇分子印迹复合微球。In the
实施例5Example 5
在实施例1~3的单分散交联甲基丙烯酸环氧丙酯微球表面键合乙烯基步骤4中,将单分散多孔交联甲基丙烯酸环氧丙酯微球加入1,4-二氧六环中,200转/分钟搅拌,室温溶胀12小时,通氮气20分钟除氧,加入甲基丙烯酸羟乙酯与1,4-二氧六环、三氟化硼乙醚的混合液,60℃搅拌8小时,该步骤的其他步骤与相应实施例相同。其他步骤与相应实施例相同,制备成17β-雌二醇分子印迹复合微球。In the
实施例6Example 6
在实施例1~5的合成17β-雌二醇分子印迹复合微球步骤5中,将17β-雌二醇、甲基丙烯酸、表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球超声分散于乙腈中,200转/分钟搅拌,室温溶胀4小时,加入乙二醇二甲基丙烯酸酯、偶氮二异丁腈,通氮气20分钟除氧,60℃聚合反应48小时,该步骤的其他步骤与相应实施例相同。其他步骤与相应实施例相同,制备成17β-雌二醇分子印迹复合微球。In Step 5 of the synthesis of 17β-estradiol molecularly imprinted composite microspheres in Examples 1-5, 17β-estradiol, methacrylic acid, and monodisperse cross-linked glycidyl methacrylate with vinyl groups bound to the surface Ultrasonic dispersion of microspheres in acetonitrile, stirring at 200 rpm, swelling at room temperature for 4 hours, adding ethylene glycol dimethacrylate and azobisisobutyronitrile, nitrogen gas for 20 minutes to remove oxygen, and polymerization at 60°C for 48 hours. Other steps of this step are the same as those in the corresponding embodiment. The other steps were the same as those in the corresponding examples to prepare 17β-estradiol molecularly imprinted composite microspheres.
实施例7Example 7
在实施例1~5的合成17β-雌二醇分子印迹复合微球步骤5中,将17β-雌二醇、甲基丙烯酸、表面键合乙烯基的单分散交联甲基丙烯酸环氧丙酯微球超声分散于乙腈中,200转/分钟搅拌,室温溶胀12小时,加入乙二醇二甲基丙烯酸酯、偶氮二异丁腈,通氮气20分钟除氧,70℃聚合反应16小时,该步骤的其他步骤与相应实施例相同。其他步骤与相应实施例相同,制备成17β-雌二醇分子印迹复合微球。In Step 5 of the synthesis of 17β-estradiol molecularly imprinted composite microspheres in Examples 1-5, 17β-estradiol, methacrylic acid, and monodisperse cross-linked glycidyl methacrylate with vinyl groups bound to the surface Ultrasonic dispersion of microspheres in acetonitrile, stirring at 200 rpm, swelling at room temperature for 12 hours, adding ethylene glycol dimethacrylate and azobisisobutyronitrile, nitrogen gas for 20 minutes to remove oxygen, and polymerization at 70°C for 16 hours. Other steps of this step are the same as those in the corresponding embodiment. The other steps were the same as those in the corresponding examples to prepare 17β-estradiol molecularly imprinted composite microspheres.
为了验证本发明的有益效果,发明人采用本发明实施例1制备的17β-雌二醇分子印迹复合微球和对比实施例1制备的非分子印迹复合微球进行了各种试验,具体试验情况如下:In order to verify the beneficial effects of the present invention, the inventors carried out various tests using the 17β-estradiol molecularly imprinted composite microspheres prepared in Example 1 of the present invention and the non-molecularly imprinted composite microspheres prepared in Comparative Example 1. The specific test conditions as follows:
实验试剂:过氧化苯甲酰(BPO,A.R.天津市福晨化学试剂厂);甲基丙烯酸环氧丙酯(GMA,Sigma-Aldrich);乙二醇二甲基丙烯酸酯(EDMA,Sigma-Aldrich);甲基丙烯酸(MAA,Sigma-Aldrich);甲基丙烯酸羟乙酯(HEMA,Sigma-Aldrich);1,4-二氧六环(A.R.天津市福晨化学试剂厂);N,N-二甲基甲酰胺(DMF,天津市福晨化学试剂厂);17β-雌二醇,雌三醇和雌酮,均采购自上海晶纯实业有限公司。Experimental reagents: benzoyl peroxide (BPO, A.R. Tianjin Fuchen Chemical Reagent Factory); glycidyl methacrylate (GMA, Sigma-Aldrich); ethylene glycol dimethacrylate (EDMA, Sigma-Aldrich ); Methacrylic acid (MAA, Sigma-Aldrich); Hydroxyethyl methacrylate (HEMA, Sigma-Aldrich); 1,4-dioxane (A.R. Tianjin Fuchen Chemical Reagent Factory); N, N- Dimethylformamide (DMF, Tianjin Fuchen Chemical Reagent Factory); 17β-estradiol, estriol and estrone were purchased from Shanghai Jingchun Industrial Co., Ltd.
1、色谱实验1. Chromatography experiment
(1)称取17β-雌二醇分子印迹复合微球(MIP)、非分子印迹复合微球(NIP)各0.8g置于30mL异丙醇中,超声匀浆10分钟,在20MPa压力下,以乙腈作为顶替液,湿法装柱(50mm×4.6mm),以乙腈为流动相,直到获得稳定的基线。以17β-雌二醇分子印迹复合微球填充的色谱柱称为印迹柱,以非分子印迹复合微球填充的色谱柱称为非印迹柱。(1) Weigh 0.8 g of 17β-estradiol molecularly imprinted composite microspheres (MIP) and non-molecularly imprinted composite microspheres (NIP) in 30 mL of isopropanol, homogenize by ultrasonic for 10 minutes, under 20 MPa pressure, Acetonitrile was used as the displacement liquid, and the column (50mm×4.6mm) was wet-packed, and acetonitrile was used as the mobile phase until a stable baseline was obtained. A chromatographic column filled with 17β-estradiol molecularly imprinted composite microspheres is called an imprinted column, and a chromatographic column filled with non-molecularly imprinted composite microspheres is called a non-imprinted column.
色谱条件:以体积分数为36%的乙腈-水溶液为流动相;流速为0.5mL/分钟;进样量为5.0μL,样品为20μg·mL-1的乙腈水溶液;检测波长为280nm。Chromatographic conditions: 36% acetonitrile-water solution as mobile phase; flow rate 0.5mL/min; injection volume 5.0μL, sample 20μg·mL -1 acetonitrile-water solution; detection wavelength 280nm.
测定数据:容量因子k′=(tR-t0)/t0,其中tR是分析物的保留时间,t0是死时间(以NaNO2测定);印迹因子IF=k′MIP/k′NIP,其中k′MIP和k′NIP分别为17β-雌二醇分子印迹复合微球和非分子印迹复合微球的容量因子;分离因子α=k1′/k2′,其中k1′和k2′分别是17β-雌二醇和雌三醇在印迹柱上的容量因子。Determination data: capacity factor k'=(t R -t 0 )/t 0 , where t R is the retention time of the analyte, t 0 is the dead time (determined by NaNO 2 ); imprinting factor IF=k' MIP /k ′ NIP , where k′ MIP and k′ NIP are the capacity factors of 17β-estradiol molecularly imprinted composite microspheres and non-molecularly imprinted composite microspheres; separation factor α=k 1 ′/k 2 ′, where k 1 ′ and k 2 ' are the capacity factors of 17β-estradiol and estriol on the blot column, respectively.
(2)17β-雌二醇在印迹柱和非印迹柱上的保留情况(2) Retention of 17β-estradiol on imprinted and non-imprinted columns
以17β-雌二醇及与其结构差异较大的白藜芦醇和辣椒碱作为研究对象,研究17β-雌二醇分子印迹复合微球和非分子印迹复合微球的选择性,结果如图1和图2所示。由图1可见,在相同的分离条件下,17β-雌二醇在印迹柱上的保留比白藜芦醇、辣椒碱强,表明17β-雌二醇分子印迹复合微球对17β-雌二醇具有一定的吸附选择性;如图2所示,相同的分离条件下,三种物质在非印迹柱上的保留时间十分接近,证明分子印迹复合微球对模板分子具有特异性选择。这是由于在17β-雌二醇分子印迹复合微球的制备过程中形成了能够与模板分子17β-雌二醇空间结构相匹配的印迹孔穴和结合位点,其对模板分子具有特异识别能力;白藜芦醇和辣椒碱的结构与17β-雌二醇的结构不相同,很难与模板分子留下的印迹孔穴相匹配,因此,17β-雌二醇分子印迹复合微球对其不具备识别能力。而非分子印迹复合微球上并不存在这样的特异性结合位点,三种物质在非印迹柱上的保留时间十分接近。Taking 17β-estradiol and resveratrol and capsaicin, which have large structural differences, as the research objects, the selectivity of 17β-estradiol molecularly imprinted composite microspheres and non-molecularly imprinted composite microspheres was studied. The results are shown in Figure 1 and Figure 2 shows. It can be seen from Figure 1 that under the same separation conditions, the retention of 17β-estradiol on the imprinted column is stronger than that of resveratrol and capsaicin, indicating that the 17β-estradiol molecularly imprinted composite microspheres have a strong effect on the retention of 17β-estradiol. It has a certain adsorption selectivity; as shown in Figure 2, under the same separation conditions, the retention times of the three substances on the non-imprinted column are very close, which proves that the molecularly imprinted composite microspheres have specific selection for template molecules. This is due to the formation of imprinted holes and binding sites that can match the spatial structure of the template molecule 17β-estradiol during the preparation of the 17β-estradiol molecularly imprinted composite microspheres, which have specific recognition capabilities for the template molecule; The structures of resveratrol and capsaicin are different from those of 17β-estradiol, and it is difficult to match with the imprinted holes left by template molecules. Therefore, 17β-estradiol molecularly imprinted composite microspheres do not have the ability to recognize them . There is no such specific binding site on non-molecularly imprinted composite microspheres, and the retention times of the three substances on non-imprinted columns are very close.
另外,选择17β-雌二醇的结构类似物雌酮作为研究对象研究分子印迹复合微球对同类物质的识别作用。由图3可以看出,雌二醇和雌酮在印迹柱上的保留时间很接近,说明17β-雌二醇分子印迹复合微球对结构类似物具有相似的保留情况。由图3、4对比可以看出,17β-雌二醇和其结构类似物雌酮在非印迹柱上的保留时间均小于在印迹柱上的保留时间,由此进一步证明分子印迹复合微球对模板分子有特异性识别作用。In addition, estrone, a structural analogue of 17β-estradiol, was selected as the research object to study the recognition effect of molecularly imprinted composite microspheres on similar substances. It can be seen from Figure 3 that the retention times of estradiol and estrone on the imprinted column are very close, indicating that the 17β-estradiol molecularly imprinted composite microspheres have similar retention of structural analogues. From the comparison of Figures 3 and 4, it can be seen that the retention time of 17β-estradiol and its structural analogue estrone on the non-imprinted column is shorter than that on the imprinted column, which further proves that the molecularly imprinted composite microspheres have a positive effect on the template. Molecules have specific recognition.
(3)pH值对分离的影响(3) Effect of pH value on separation
分别以乙腈与pH为3、5、7、9、11的PBS缓冲液(25mmol/L的磷酸盐缓冲液)的体积比为36∶64的混合液为流动相,考察流动相的pH对17β-雌二醇及雌三醇在印迹柱上保留情况的影响。结果如表1所示。Respectively with acetonitrile and
表1流动相中磷酸盐酸冲液的pH值对分离的影响Influence of the pH value of the phosphate hydrochloric acid wash solution in the mobile phase on the separation in Table 1
由表1可见,随着pH的增大,17β-雌二醇在印迹柱和非印迹柱上的保留行为稍有变小,但变化不明显,说明17β-雌二醇分子印迹复合微球有较强的耐酸碱性,稳定性好;17β-雌二醇分子印迹复合微球的识别能力是由印迹过程产生的且受pH的影响很小。It can be seen from Table 1 that as the pH increases, the retention behavior of 17β-estradiol on the imprinted column and non-imprinted column becomes slightly smaller, but the change is not obvious, indicating that the 17β-estradiol molecularly imprinted composite microspheres have Strong acid and alkali resistance and good stability; the recognition ability of 17β-estradiol molecularly imprinted composite microspheres is produced by the imprinting process and is slightly affected by pH.
(4)柱温对分离的影响(4) Effect of column temperature on separation
以体积分数为36%的乙腈水溶液为流动相,流速为0.5mL/分钟,考察不同温度(20、30、40、50、60℃)对17β-雌二醇及雌三醇在印迹柱上的影响。实验结果见表2。With 36% acetonitrile aqueous solution as the mobile phase and a flow rate of 0.5mL/min, the effects of different temperatures (20, 30, 40, 50, 60° C.) on 17β-estradiol and estriol on the imprinted column were investigated. Influence. The experimental results are shown in Table 2.
表2柱温对分离的影响Table 2 The influence of column temperature on separation
由表2可见,在20℃时分离因子达到最高值4.06,随着温度的升高,17β-雌二醇与雌三醇的容量因子均有所降低,但变化不大,而印迹因子变化不明显,说明热力学因素对印迹和非印迹微球的稳定性几乎没有影响,进一步证明了本发明制备的17β-雌二醇分子印迹复合微球的热稳定性很好。It can be seen from Table 2 that the separation factor reaches the highest value of 4.06 at 20°C. As the temperature increases, the capacity factors of 17β-estradiol and estriol decrease, but the change is not large, while the imprinting factor changes little. Obviously, it shows that thermodynamic factors have almost no influence on the stability of the imprinted and non-imprinted microspheres, which further proves that the thermal stability of the 17β-estradiol molecularly imprinted composite microspheres prepared by the present invention is very good.
综合实验(2)~(4)的实验结果,说明本发明制备的17β-雌二醇分子印迹复合微球的对17β-雌二醇及其结构类似物具有强的特异识别能力,抗酸碱性,pH使用范围宽于硅胶的2~7.5,热稳定性好,其性能几乎不受温度的影响,可在多领域中使用。The experimental results of comprehensive experiments (2) to (4) show that the 17β-estradiol molecularly imprinted composite microspheres prepared by the present invention have strong specific recognition ability to 17β-estradiol and its structural analogues, and are resistant to acid and alkali. The pH range is wider than that of silica gel 2-7.5. It has good thermal stability and its performance is almost not affected by temperature. It can be used in many fields.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110194705A CN102382273B (en) | 2011-07-12 | 2011-07-12 | Preparation method of 17 beta-estradiol molecular-imprinted composite microspheres |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110194705A CN102382273B (en) | 2011-07-12 | 2011-07-12 | Preparation method of 17 beta-estradiol molecular-imprinted composite microspheres |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102382273A CN102382273A (en) | 2012-03-21 |
CN102382273B true CN102382273B (en) | 2012-10-03 |
Family
ID=45822150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110194705A Expired - Fee Related CN102382273B (en) | 2011-07-12 | 2011-07-12 | Preparation method of 17 beta-estradiol molecular-imprinted composite microspheres |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102382273B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102718984B (en) * | 2012-06-28 | 2013-10-16 | 陕西师范大学 | Preparation method of ofloxacin and 17beta-estradiol double-template molecularly-imprinted composite microsphere |
CN104483295B (en) * | 2014-11-27 | 2015-08-19 | 陕西师范大学 | Molecular engram microsphere based on boric acid fluorescence probe detects the method for glycoprotein |
CN105107482A (en) * | 2015-09-11 | 2015-12-02 | 中国农业科学院农业质量标准与检测技术研究所 | Preparation method for molecular imprinting material and molecular imprinting material prepared through preparation method |
CN114441778A (en) * | 2022-01-27 | 2022-05-06 | 四川沃文特生物技术有限公司 | A detection kit for the determination of estradiol |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102037035A (en) * | 2008-05-23 | 2011-04-27 | 昭和电工株式会社 | Curable composition containing a reactive (meth)acrylate polymer and a cured product thereof |
-
2011
- 2011-07-12 CN CN201110194705A patent/CN102382273B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102037035A (en) * | 2008-05-23 | 2011-04-27 | 昭和电工株式会社 | Curable composition containing a reactive (meth)acrylate polymer and a cured product thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102382273A (en) | 2012-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hajizadeh et al. | Cryogelation of molecularly imprinted nanoparticles: A macroporous structure as affinity chromatography column for removal of β-blockers from complex samples | |
CN102718984B (en) | Preparation method of ofloxacin and 17beta-estradiol double-template molecularly-imprinted composite microsphere | |
CN102617869B (en) | Hydrophilic modification product of polyacrylate and its copolymer material and method of hydrophilic modification | |
CN103497277B (en) | Scutellarin molecularly imprinted polymer and its preparation method and application | |
CN102382273B (en) | Preparation method of 17 beta-estradiol molecular-imprinted composite microspheres | |
CN101246150B (en) | A preparation method of tetracycline molecularly imprinted monolithic column | |
CN111151227A (en) | Semi-molecular imprinting material and preparation method and application thereof | |
CN103554363B (en) | The preparations and applicatio of nano silicon butyldoxycycline molecularly imprinted polymer | |
CN101733081A (en) | Method for preparing molecularly imprinted microspheres on surface of polymer carrier | |
CN101381430A (en) | Molecular imprinting polymer of curcumin and its preparation method and application | |
CN103304752A (en) | Method for preparing silica gel bisphenol A molecularly imprinted polymer by half-covalent process by taking diamine A as template | |
CN102755881A (en) | Basic orange II molecular imprinting solid-phase extraction filler, solid-phase extraction column and preparation methods and application thereof | |
CN102135527B (en) | Method for detecting antibiotic residue in soil by using matrix solid-phase dispersion technique | |
CN101628955B (en) | Method for preparing molecular imprinted polymer for recognizing chloromycetin, thiamphenicol and florfenicol simultaneously | |
CN103626938B (en) | A kind of preparation method of mezlocillin sodium silica gel surface molecularly imprinted polymer | |
CN101757896B (en) | Preparation method of molecularly imprinted polymer on nano-silica gel surfaces of sulfonylurea herbicides | |
Zhu et al. | Development and characterization of molecularly imprinted polymer microspheres for the selective detection of kaempferol in traditional Chinese medicines | |
Jiang et al. | Selective molecularly imprinted stationary phases for Bisphenol A analysis prepared by modified precipitation polymerization | |
CN102250285A (en) | Semi-covalent molecularly imprinted polymer used for selectivity separating phenols, preparation method thereof, and application thereof | |
CN102539587B (en) | Preparation method of halofuginone molecularly-imprinted solid-phase extraction small column and application | |
CN101851318A (en) | Preparation method of punicalagin molecularly imprinted polymer microspheres | |
CN102532391B (en) | Method for preparing 17β-estradiol molecularly imprinted polymer using mixed template | |
Niu et al. | Synthesis of chlorogenic acid imprinted chromatographic packing by surface-initiated atom transfer radical polymerization and its application | |
CN105237770A (en) | Preparation method of molecularly imprinted polymer | |
CN102585117B (en) | A method for preparing surface molecularly imprinted polymer chromatographic column |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121003 Termination date: 20130712 |